For Immediate Release
Chicago, IL - December 30, 2011 - Four free stock picks are
being made available today on Zacks.com. The industry's leading
independent research firm highlights one Zacks #1 Rank Strong Buy
or a Zacks #2 Rank Buy stock for each of the four main styles of
investing: Aggressive Growth, Growth & Income, Momentum, and
Value.
The four highlighted picks are:
Chemtura Corporation
(
CHMT
),
Cardinal Health, Inc.
(
CAH
),
HiTech Pharmacal Co, Inc.
(
HITK
) and
Gardner Denver, Inc.
(
GDI
).
Today, Zacks is promoting its ''Buy'' stock recommendations.
Four daily picks are offered free.
http://at.zacks.com/?id=88
From 1988 through the present - a period that included serious
corrections and recessions - the Zacks #1 Rank Stocks have nearly
tripled the market with a fully documented average gain of +28% per
year.
Here is a summary of today's selected stocks that are now
highly rated by
Zacks:
Aggressive Growth -
Chemtura Corporation
(
CHMT
)
Chemtura Corporation analysts move earnings estimates higher.
Zacks Guide to Aggressive Growth Investing (free!)
-
http://at.zacks.com/?id=4309
Growth & Income -
Cardinal Health, Inc.
(
CAH
)
Cardinal Health, Inc. carried its strong momentum into the first
quarter of its fiscal 2012 and delivered its 9th consecutive
positive earnings surprise. Analysts raised their estimates after
the strong quarter for both 2012 and 2013, sending the stock to a
Zacks #2 Rank (Buy).
Zacks Guide to Growth & Income Investing
(free!)
-
http://at.zacks.com/?id=4310
Momentum -
HiTech Pharmacal Co, Inc.
(
HITK
)
HiTech Pharmacal Co, Inc. just hit a new all-time high after
reporting strong Q3 results that included an impressive 35%
earnings surprise. With estimates on the rise and a high industry
rank, this Zacks #1 rank stock is a solid pick for momentum.
Zacks Guide to Momentum Investing (free!):
http://at.zacks.com/?id=4311
Value -
Gardner Denver, Inc.
(
GDI
)
Gardner Denver, Inc. is still on track for double digit earnings
growth in 2012 after posting several record quarters in 2011. This
Zacks #1 Rank (strong buy) has attractive valuations with a forward
P/E of 13.8.
Zacks Guide to Value Investing (free!) -
http://at.zacks.com/?id=4312
How to Regularly Access Top Zacks Rank Picks for Free -
http://at.zacks.com/?id=7154
Underlying the four free stock picks is a simple truth that
first appeared in a
Financial Analysts Journal
article published in 1979. Leonard Zacks, a Ph.D. from M.I.T. found
that
"earnings estimate revisions are the most powerful force
impacting stock prices."
Zacks #1 Rank is awarded to a stock when analysts sharply
upgrade their estimates of what the company will earn.
Today, Zacks is promoting its stock recommendations by offering
four daily picks free to those who register here:
http://at.zacks.com/?id=7155
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc.,
which was formed in 1978 by Len Zacks. The company continually
processes stock reports issued by 3,000 analysts from 150 brokerage
firms. It monitors more than 200,000 earnings estimates,
looking for changes.
Then, when changes are discovered, they're applied to help
assign more than 4,400 stocks into five Zacks Rank categories: #1
Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This
proprietary stock-picking system continues to outperform the market
by a nearly 3-to-1 margin.
More Free Stock Picks
Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are
released on the free email newsletter,
Profit from the Pros
. Investors are invited to register for their free subscription
here:
http://at.zacks.com/?id=91
Follow us on Twitter:
http://twitter.com/zacksresearch
Join us on Facebook:
http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with
affiliated entities (including a broker-dealer and an investment
adviser), which may engage in transactions involving the foregoing
securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an
offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Visit
http://www.zacks.com/performance
for information about the performance numbers displayed in this
press release.
CARDINAL HEALTH (
CAH
): Free Stock Analysis Report
CHEMTURA CORP (
CHMT
): Free Stock Analysis Report
GARDNER DENVER (
GDI
): Free Stock Analysis Report
HI TECH PHARMA (
HITK
): Free Stock Analysis Report
To read this article on Zacks.com click here.